Can Stem Cell Therapy Heal Hips, Shoulders, and Knees long term?
- 2 days ago
- 2 min read
Top Long-Term Clinical Studies on Stem Cells for Knees & Hips
Just as long-term research proves that stem cell therapy can repair torn shoulder tendons and prevent shoulder replacements, long-term studies on knees and hips confirm that stem cell interventions create lasting structural preservation and allow patients to avoid total joint replacement surgery.
Top Long-Term Studies for Knee Regeneration & Surgery Avoidance
1. The Landmark 15-Year Follow-Up Study (Hernigou et al.)
Focus: 15-year knee preservation, cartilage/subchondral bone repair, and avoiding Total Knee Arthroplasty (TKA).
Key Findings:
In a 15-year randomized trial, Dr. Philippe Hernigou tracked knee osteoarthritis patients receiving bone marrow-derived stem cell (MSC) therapy.
At the 15-year mark, 80% to 82% of stem cell-treated knees avoided knee replacement surgery.
MRI evaluations confirmed significant regression of painful subchondral bone marrow lesions over 24 months, proving that stem cells alter the long-term biological environment of the joint rather than providing temporary pain relief.
2. The 15-Year Comparative Study vs. Total Knee Replacement
Focus: Direct comparison of stem cell therapy vs. Total Knee Replacement (TKA) over 15 years.
Key Findings:
Patients receiving stem cell therapy achieved a 16.3-point functional improvement (Knee Society Score) compared to an 8.9-point improvement in those receiving total knee replacement.
The stem cell cohort experienced zero re-operations, significantly lower complication rates (e.g., 2% blood clot risk vs. 12% in the replacement group), and 70% of patients explicitly preferred their stem-cell-treated knee over a replaced joint.
Top Long-Term Studies for Hip Preservation & Surgery Avoidance
1. The 10-Year Hip Preservation & Osteonecrosis Trial (Hernigou et al.)
Focus: 5- to 10-year follow-up for hip preservation, bone repair, and avoiding Total Hip Replacement (THA).
Key Findings:
In a multi-year study evaluating 189 degenerated hips, bone marrow-derived stem cell injections delivered sustained, long-term functional recovery and pain reduction.
The majority of patients achieved long-term satisfaction and successfully avoided total hip replacement surgery.
Researchers concluded that stem cell therapy is a primary method for long-term joint preservation.
2. The 18-Year Hip Survival Cohort Study
Focus: Ultra long-term joint survival and arthroplasty avoidance.
Key Findings:
Following 534 patients for up to 18 years post-stem cell therapy, researchers found that 84.3% of patients never required a total hip replacement.
Serial X-rays and MRIs confirmed long-term structural stabilization of the hip joint, proving multi-decade durability.
Summary Comparison
Clinical Metric | Traditional Joint Replacement (TKA / THA) | Long-Term Stem Cell Therapy |
15-Year Joint Survival Rate | Implant wear, revision risk (~1% per year) | 80% to 84%+ native joint preservation |
Tissue Architecture | Surgical amputation of bone/cartilage | Preserves 100% native tissue & bone structure |
Complication Rates | Higher risk of infection, clots, blood transfusion | Extremely low complication profile |
STEM CELL THERAPY IS NOT FDA APPROVED
Comments